25 XP   0   0   10

Sunmax Biotechnology Co Ltd
Buy, Hold or Sell?

Let's analyse Sunmax Biotechnology Co Ltd together

PenkeI guess you are interested in Sunmax Biotechnology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sunmax Biotechnology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sunmax Biotechnology Co Ltd

I send you an email if I find something interesting about Sunmax Biotechnology Co Ltd.

Quick analysis of Sunmax Biotechnology Co Ltd (30 sec.)










What can you expect buying and holding a share of Sunmax Biotechnology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
NT$23.22
Expected worth in 1 year
NT$24.40
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
NT$1.18
Return On Investment
0.5%

For what price can you sell your share?

Current Price per Share
NT$241.00
Expected price per share
NT$195.00 - NT$287.97
How sure are you?
50%

1. Valuation of Sunmax Biotechnology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

NT$241.00

Intrinsic Value Per Share

NT$103.91 - NT$123.01

Total Value Per Share

NT$127.13 - NT$146.23

2. Growth of Sunmax Biotechnology Co Ltd (5 min.)




Is Sunmax Biotechnology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$39.5m$34.8m$5.2m13.0%

How much money is Sunmax Biotechnology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.5m$3.9m$593.3k13.0%
Net Profit Margin18.8%39.0%--

How much money comes from the company's main activities?

3. Financial Health of Sunmax Biotechnology Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#510 / 1031

Most Revenue
#323 / 1031

Most Profit
#100 / 1031

Most Efficient
#85 / 1031

What can you expect buying and holding a share of Sunmax Biotechnology Co Ltd? (5 min.)

Welcome investor! Sunmax Biotechnology Co Ltd's management wants to use your money to grow the business. In return you get a share of Sunmax Biotechnology Co Ltd.

What can you expect buying and holding a share of Sunmax Biotechnology Co Ltd?

First you should know what it really means to hold a share of Sunmax Biotechnology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sunmax Biotechnology Co Ltd is NT$241.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sunmax Biotechnology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sunmax Biotechnology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$23.22. Based on the TTM, the Book Value Change Per Share is NT$0.30 per quarter. Based on the YOY, the Book Value Change Per Share is NT$1.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sunmax Biotechnology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps0.110.0%0.080.0%0.070.0%0.050.0%0.050.0%
Usd Book Value Change Per Share0.110.0%0.010.0%0.040.0%0.040.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.140.1%0.050.0%0.050.0%
Usd Total Gains Per Share0.110.0%0.010.0%0.180.1%0.090.0%0.090.0%
Usd Price Per Share6.10-5.50-3.80-3.23-3.23-
Price to Earnings Ratio14.40-16.38-12.99-15.47-15.47-
Price-to-Total Gains Ratio55.45-35.45-25.71-25.55-25.55-
Price to Book Ratio8.40-7.74-5.90-5.87-5.87-
Price-to-Total Gains Ratio55.45-35.45-25.71-25.55-25.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.5433
Number of shares132
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.05
Usd Book Value Change Per Share0.010.04
Usd Total Gains Per Share0.010.09
Gains per Quarter (132 shares)1.2212.01
Gains per Year (132 shares)4.8848.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105-5291938
20100583886
301558758134
40201011577182
50241514496230
602920173115278
703425202134326
803930231154374
904435260173422
1004940288192470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%19.01.00.095.0%19.01.00.095.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%14.06.00.070.0%14.06.00.070.0%
Dividend per Share0.00.04.00.0%8.00.04.066.7%15.00.05.075.0%15.00.05.075.0%15.00.05.075.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%18.02.00.090.0%18.02.00.090.0%

Fundamentals of Sunmax Biotechnology Co Ltd

About Sunmax Biotechnology Co Ltd

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets medical-grade collagen-based medical devices in Asia. The company offers Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes; and dermal fillers, such as Sunmax collagen implant I-Plus and Sumax collagen implant I for the correction of facial defects, such as the fill up of wrinkles. It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge. In addition, the company offers Sunmax collagen bone graft matrix that provides a bone void filler that is resorbed and replaced with bone during the healing process; and skincare products comprising Sunmax 6 collagen facial cleanser, Sunmax 7 collagen essence, Sunmax 8 active collagen essence mask, Sunmax 9 collagen refining cream, Sunmax 10 collagen eye renewal cream, Sunmax 11 collagen moisturizing cream, Sunmax 15 Collagen MesoRepair, and Sunmax Collagen Peptide that are used as aftercare of dermal filler treatment. Sunmax Biotechnology Co., Ltd. was founded in 2001 and is based in Tainan City, Taiwan.

Fundamental data was last updated by Penke on 2024-03-26 08:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Sunmax Biotechnology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sunmax Biotechnology Co Ltd earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 38.9% means that NT$0.39 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 38.9%. The company is making a huge profit. +2
  • The TTM is 18.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ38.9%TTM18.8%+20.1%
TTM18.8%YOY39.0%-20.3%
TTM18.8%5Y24.8%-6.0%
5Y24.8%10Y24.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ38.9%-171.8%+210.7%
TTM18.8%-205.8%+224.6%
YOY39.0%-262.1%+301.1%
5Y24.8%-455.6%+480.4%
10Y24.8%-589.0%+613.8%
1.1.2. Return on Assets

Shows how efficient Sunmax Biotechnology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • 9.5% Return on Assets means that Sunmax Biotechnology Co Ltd generated NT$0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 9.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.5%TTM7.4%+2.0%
TTM7.4%YOY7.7%-0.3%
TTM7.4%5Y5.2%+2.2%
5Y5.2%10Y5.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5%-12.5%+22.0%
TTM7.4%-12.2%+19.6%
YOY7.7%-11.2%+18.9%
5Y5.2%-13.4%+18.6%
10Y5.2%-14.7%+19.9%
1.1.3. Return on Equity

Shows how efficient Sunmax Biotechnology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • 14.6% Return on Equity means Sunmax Biotechnology Co Ltd generated NT$0.15 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 14.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.6%TTM11.6%+3.0%
TTM11.6%YOY11.3%+0.2%
TTM11.6%5Y7.9%+3.7%
5Y7.9%10Y7.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.6%-15.8%+30.4%
TTM11.6%-15.7%+27.3%
YOY11.3%-13.9%+25.2%
5Y7.9%-18.3%+26.2%
10Y7.9%-19.2%+27.1%

1.2. Operating Efficiency of Sunmax Biotechnology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sunmax Biotechnology Co Ltd is operating .

  • Measures how much profit Sunmax Biotechnology Co Ltd makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM27.8%-27.8%
TTM27.8%YOY55.4%-27.6%
TTM27.8%5Y36.2%-8.4%
5Y36.2%10Y36.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM27.8%-210.1%+237.9%
YOY55.4%-279.7%+335.1%
5Y36.2%-459.9%+496.1%
10Y36.2%-596.9%+633.1%
1.2.2. Operating Ratio

Measures how efficient Sunmax Biotechnology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.63 means that the operating costs are NT$0.63 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 0.630. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.577. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.630TTM0.577+0.052
TTM0.577YOY0.596-0.019
TTM0.5775Y0.731-0.153
5Y0.73110Y0.7310.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6302.861-2.231
TTM0.5773.193-2.616
YOY0.5963.615-3.019
5Y0.7315.560-4.829
10Y0.7317.396-6.665

1.3. Liquidity of Sunmax Biotechnology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sunmax Biotechnology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.01 means the company has NT$2.01 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 2.007. The company is able to pay all its short-term debts. +1
  • The TTM is 1.973. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.007TTM1.973+0.034
TTM1.973YOY2.320-0.347
TTM1.9735Y3.336-1.363
5Y3.33610Y3.3360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0073.986-1.979
TTM1.9734.440-2.467
YOY2.3205.552-3.232
5Y3.3366.158-2.822
10Y3.3366.492-3.156
1.3.2. Quick Ratio

Measures if Sunmax Biotechnology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.30 means the company can pay off NT$0.30 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 0.305. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.559. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.305TTM0.559-0.254
TTM0.559YOY0.240+0.319
TTM0.5595Y0.621-0.062
5Y0.62110Y0.6210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3053.638-3.333
TTM0.5594.168-3.609
YOY0.2405.515-5.275
5Y0.6216.012-5.391
10Y0.6216.209-5.588

1.4. Solvency of Sunmax Biotechnology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sunmax Biotechnology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sunmax Biotechnology Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.35 means that Sunmax Biotechnology Co Ltd assets are financed with 35.2% credit (debt) and the remaining percentage (100% - 35.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 0.352. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.338. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.352TTM0.338+0.014
TTM0.338YOY0.314+0.024
TTM0.3385Y0.329+0.009
5Y0.32910Y0.3290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3520.335+0.017
TTM0.3380.330+0.008
YOY0.3140.267+0.047
5Y0.3290.367-0.038
10Y0.3290.378-0.049
1.4.2. Debt to Equity Ratio

Measures if Sunmax Biotechnology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 54.3% means that company has NT$0.54 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sunmax Biotechnology Co Ltd:

  • The MRQ is 0.543. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.575. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.543TTM0.575-0.032
TTM0.575YOY0.465+0.110
TTM0.5755Y0.514+0.060
5Y0.51410Y0.5140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5430.376+0.167
TTM0.5750.398+0.177
YOY0.4650.334+0.131
5Y0.5140.429+0.085
10Y0.5140.476+0.038

2. Market Valuation of Sunmax Biotechnology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Sunmax Biotechnology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Sunmax Biotechnology Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 14.40 means the investor is paying NT$14.40 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sunmax Biotechnology Co Ltd:

  • The EOD is 17.792. Based on the earnings, the company is fair priced.
  • The MRQ is 14.396. Based on the earnings, the company is underpriced. +1
  • The TTM is 16.385. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.792MRQ14.396+3.396
MRQ14.396TTM16.385-1.988
TTM16.385YOY12.989+3.396
TTM16.3855Y15.474+0.911
5Y15.47410Y15.4740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD17.792-2.643+20.435
MRQ14.396-2.418+16.814
TTM16.385-2.742+19.127
YOY12.989-4.123+17.112
5Y15.474-6.257+21.731
10Y15.474-6.478+21.952
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sunmax Biotechnology Co Ltd:

  • The EOD is 18.788. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.202. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 7.536. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD18.788MRQ15.202+3.586
MRQ15.202TTM7.536+7.666
TTM7.536YOY10.082-2.546
TTM7.5365Y12.185-4.650
5Y12.18510Y12.1850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD18.788-3.244+22.032
MRQ15.202-2.939+18.141
TTM7.536-3.478+11.014
YOY10.082-5.592+15.674
5Y12.185-8.473+20.658
10Y12.185-8.881+21.066
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sunmax Biotechnology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.40 means the investor is paying NT$8.40 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of Sunmax Biotechnology Co Ltd:

  • The EOD is 10.378. Based on the equity, the company is expensive. -2
  • The MRQ is 8.397. Based on the equity, the company is overpriced. -1
  • The TTM is 7.742. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.378MRQ8.397+1.981
MRQ8.397TTM7.742+0.655
TTM7.742YOY5.897+1.845
TTM7.7425Y5.867+1.876
5Y5.86710Y5.8670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.3782.124+8.254
MRQ8.3972.041+6.356
TTM7.7422.118+5.624
YOY5.8972.915+2.982
5Y5.8673.682+2.185
10Y5.8674.114+1.753
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sunmax Biotechnology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.5170.295+1091%1.262+179%1.161+203%1.161+203%
Book Value Per Share--23.22123.485-1%20.430+14%17.276+34%17.276+34%
Current Ratio--2.0071.973+2%2.320-13%3.336-40%3.336-40%
Debt To Asset Ratio--0.3520.338+4%0.314+12%0.329+7%0.329+7%
Debt To Equity Ratio--0.5430.575-6%0.465+17%0.514+6%0.514+6%
Dividend Per Share----0%4.400-100%1.745-100%1.745-100%
Eps--3.3862.687+26%2.322+46%1.477+129%1.477+129%
Free Cash Flow Per Share--3.2071.857+73%0.957+235%1.199+167%1.199+167%
Free Cash Flow To Equity Per Share--3.2071.736+85%-0.288+109%0.605+430%0.605+430%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--123.007--------
Intrinsic Value_10Y_min--103.912--------
Intrinsic Value_1Y_max--6.068--------
Intrinsic Value_1Y_min--5.957--------
Intrinsic Value_3Y_max--23.002--------
Intrinsic Value_3Y_min--21.863--------
Intrinsic Value_5Y_max--45.685--------
Intrinsic Value_5Y_min--41.993--------
Market Cap13125583000.000+19%10620285000.0009565064375.000+11%6618616075.000+60%5617041505.000+89%5617041505.000+89%
Net Profit Margin--0.3890.188+107%0.3900%0.248+57%0.248+57%
Operating Margin---0.278-100%0.554-100%0.362-100%0.362-100%
Operating Ratio--0.6300.577+9%0.596+6%0.731-14%0.731-14%
Pb Ratio10.378+19%8.3977.742+8%5.897+42%5.867+43%5.867+43%
Pe Ratio17.792+19%14.39616.385-12%12.989+11%15.474-7%15.474-7%
Price Per Share241.000+19%195.000175.625+11%121.525+60%103.135+89%103.135+89%
Price To Free Cash Flow Ratio18.788+19%15.2027.536+102%10.082+51%12.185+25%12.185+25%
Price To Total Gains Ratio68.526+19%55.44735.448+56%25.706+116%25.553+117%25.553+117%
Quick Ratio--0.3050.559-46%0.240+27%0.621-51%0.621-51%
Return On Assets--0.0950.074+27%0.077+22%0.052+80%0.052+80%
Return On Equity--0.1460.116+26%0.113+29%0.079+85%0.079+85%
Total Gains Per Share--3.5170.295+1091%5.662-38%2.906+21%2.906+21%
Usd Book Value--39585047.40040034351.075-1%34827322.200+14%29450465.785+34%29450465.785+34%
Usd Book Value Change Per Share--0.1100.009+1091%0.039+179%0.036+203%0.036+203%
Usd Book Value Per Share--0.7270.735-1%0.639+14%0.541+34%0.541+34%
Usd Dividend Per Share----0%0.138-100%0.055-100%0.055-100%
Usd Eps--0.1060.084+26%0.073+46%0.046+129%0.046+129%
Usd Free Cash Flow--5466576.3003165470.725+73%1631950.700+235%2044476.875+167%2044476.875+167%
Usd Free Cash Flow Per Share--0.1000.058+73%0.030+235%0.038+167%0.038+167%
Usd Free Cash Flow To Equity Per Share--0.1000.054+85%-0.009+109%0.019+430%0.019+430%
Usd Market Cap410830747.900+19%332414920.500299386514.938+11%207162683.148+60%175813399.107+89%175813399.107+89%
Usd Price Per Share7.543+19%6.1045.497+11%3.804+60%3.228+89%3.228+89%
Usd Profit--5772690.3004551599.050+27%3958260.600+46%2511846.910+130%2511846.910+130%
Usd Revenue--14834447.2006905852.025+115%10108241.100+47%7006803.915+112%7006803.915+112%
Usd Total Gains Per Share--0.1100.009+1091%0.177-38%0.091+21%0.091+21%
 EOD+4 -4MRQTTM+23 -10YOY+21 -145Y+25 -1010Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Sunmax Biotechnology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.792
Price to Book Ratio (EOD)Between0-110.378
Net Profit Margin (MRQ)Greater than00.389
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.305
Current Ratio (MRQ)Greater than12.007
Debt to Asset Ratio (MRQ)Less than10.352
Debt to Equity Ratio (MRQ)Less than10.543
Return on Equity (MRQ)Greater than0.150.146
Return on Assets (MRQ)Greater than0.050.095
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Sunmax Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5075.689
Ma 20Greater thanMa 50212.850
Ma 50Greater thanMa 100206.060
Ma 100Greater thanMa 200203.480
OpenGreater thanClose231.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in TWD. All numbers in thousands.

Summary
Total Assets1,951,388
Total Liabilities686,690
Total Stockholder Equity1,264,698
 As reported
Total Liabilities 686,690
Total Stockholder Equity+ 1,264,698
Total Assets = 1,951,388

Assets

Total Assets1,951,388
Total Current Assets917,884
Long-term Assets1,033,504
Total Current Assets
Cash And Cash Equivalents 666,672
Short-term Investments 138,755
Net Receivables 536
Inventory 83,478
Other Current Assets 24,632
Total Current Assets  (as reported)917,884
Total Current Assets  (calculated)914,073
+/- 3,811
Long-term Assets
Property Plant Equipment 903,005
Intangible Assets 3,076
Long-term Assets Other 1,358
Long-term Assets  (as reported)1,033,504
Long-term Assets  (calculated)907,439
+/- 126,065

Liabilities & Shareholders' Equity

Total Current Liabilities457,313
Long-term Liabilities229,377
Total Stockholder Equity1,264,698
Total Current Liabilities
Short Long Term Debt 6,699
Accounts payable 12,892
Other Current Liabilities 3,104
Total Current Liabilities  (as reported)457,313
Total Current Liabilities  (calculated)22,695
+/- 434,618
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt163,586
Long-term Liabilities Other 12,173
Long-term Liabilities  (as reported)229,377
Long-term Liabilities  (calculated)175,759
+/- 53,618
Total Stockholder Equity
Retained Earnings 595,799
Total Stockholder Equity (as reported)1,264,698
Total Stockholder Equity (calculated)595,799
+/- 668,899
Other
Capital Stock544,630
Common Stock Shares Outstanding 54,463
Net Invested Capital 1,271,397
Net Working Capital 460,571
Property Plant and Equipment Gross 1,038,318



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
757,894
941,287
1,011,968
998,667
1,112,652
1,000,108
1,171,003
1,234,451
1,364,107
1,422,562
1,470,006
1,530,283
1,484,016
1,627,222
1,736,020
1,652,954
1,640,913
2,000,640
2,297,292
1,951,388
1,951,3882,297,2922,000,6401,640,9131,652,9541,736,0201,627,2221,484,0161,530,2831,470,0061,422,5621,364,1071,234,4511,171,0031,000,1081,112,652998,6671,011,968941,287757,894
   > Total Current Assets 
579,696
635,588
735,825
723,981
825,714
754,548
869,939
910,917
965,528
977,706
1,007,629
969,370
787,572
870,545
926,145
791,503
411,493
1,126,924
1,283,426
917,884
917,8841,283,4261,126,924411,493791,503926,145870,545787,572969,3701,007,629977,706965,528910,917869,939754,548825,714723,981735,825635,588579,696
       Cash And Cash Equivalents 
314,334
442,551
508,690
458,799
583,491
540,271
659,643
709,023
778,580
850,735
870,561
760,095
602,549
705,764
763,556
614,809
80,616
792,849
1,093,897
666,672
666,6721,093,897792,84980,616614,809763,556705,764602,549760,095870,561850,735778,580709,023659,643540,271583,491458,799508,690442,551314,334
       Short-term Investments 
187,187
132,744
151,459
21,951
144,421
149,266
147,663
0
131,014
76,788
76,281
93,371
76,788
78,789
77,818
80,340
227,368
229,002
76,827
138,755
138,75576,827229,002227,36880,34077,81878,78976,78893,37176,28176,788131,0140147,663149,266144,42121,951151,459132,744187,187
       Net Receivables 
18,616
4,204
17,022
22,203
38,387
9,366
14,958
12,204
10,512
6,530
7,711
6,910
8,431
7,204
6,600
8,212
32,075
6,518
6,668
536
5366,6686,51832,0758,2126,6007,2048,4316,9107,7116,53010,51212,20414,9589,36638,38722,20317,0224,20418,616
       Inventory 
23,188
29,673
33,609
38,570
41,195
40,517
40,142
48,095
25,332
32,840
42,495
52,913
54,740
55,686
68,682
76,630
59,122
75,942
84,709
83,478
83,47884,70975,94259,12276,63068,68255,68654,74052,91342,49532,84025,33248,09540,14240,51741,19538,57033,60929,67323,188
       Other Current Assets 
7,314
14,962
20,760
177,681
4,788
3,285
7,533
13,935
20,090
10,813
10,581
56,081
45,064
23,102
9,489
13,498
10,789
22,613
21,325
24,632
24,63221,32522,61310,78913,4989,48923,10245,06456,08110,58110,81320,09013,9357,5333,2854,788177,68120,76014,9627,314
   > Long-term Assets 
0
305,699
276,143
274,686
286,938
245,560
301,064
323,534
398,579
444,856
462,377
560,913
696,444
756,677
809,875
861,451
1,229,420
873,716
1,013,866
1,033,504
1,033,5041,013,866873,7161,229,420861,451809,875756,677696,444560,913462,377444,856398,579323,534301,064245,560286,938274,686276,143305,6990
       Property Plant Equipment 
9,930
169,535
138,276
137,699
138,650
100,809
170,093
203,212
277,180
286,891
299,134
386,571
485,562
519,848
555,765
711,582
722,014
749,072
882,725
903,005
903,005882,725749,072722,014711,582555,765519,848485,562386,571299,134286,891277,180203,212170,093100,809138,650137,699138,276169,5359,930
       Long Term Investments 
64,080
33,000
32,700
32,940
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000032,94032,70033,00064,080
       Intangible Assets 
9,686
11,414
10,743
9,555
0
0
0
0
0
0
0
0
0
3,636
4,079
3,945
0
3,714
3,288
3,076
3,0763,2883,71403,9454,0793,6360000000009,55510,74311,4149,686
       Long-term Assets Other 
0
9,190
96
96
16,930
16,914
582
438
19,181
52,514
667
211
155
2,076
1,866
1,781
0
1,563
1,414
1,358
1,3581,4141,56301,7811,8662,07615521166752,51419,18143858216,91416,93096969,1900
> Total Liabilities 
109,884
265,113
374,316
306,185
435,824
272,470
464,775
506,090
475,269
472,394
476,680
604,786
460,439
459,851
676,563
452,583
315,636
547,561
1,224,135
686,690
686,6901,224,135547,561315,636452,583676,563459,851460,439604,786476,680472,394475,269506,090464,775272,470435,824306,185374,316265,113109,884
   > Total Current Liabilities 
71,480
77,356
216,990
152,818
275,623
151,349
294,183
346,829
294,513
303,221
338,145
471,926
333,948
317,157
552,206
316,513
196,614
444,665
1,020,390
457,313
457,3131,020,390444,665196,614316,513552,206317,157333,948471,926338,145303,221294,513346,829294,183151,349275,623152,818216,99077,35671,480
       Short-term Debt 
24,000
3,193
4,059
6,427
5,053
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000005,0536,4274,0593,19324,000
       Short Long Term Debt 
24,000
3,193
4,059
6,427
5,053
2,564
13,762
7,605
5,692
8,056
8,178
6,547
9,884
5,736
7,399
5,033
7,246
2,189
3,916
6,699
6,6993,9162,1897,2465,0337,3995,7369,8846,5478,1788,0565,6927,60513,7622,5645,0536,4274,0593,19324,000
       Accounts payable 
5,383
1,740
3,867
5,377
9,882
7,047
16,195
9,121
7,181
12,648
15,038
18,693
14,954
8,402
11,279
18,519
9,300
6,781
22,485
12,892
12,89222,4856,7819,30018,51911,2798,40214,95418,69315,03812,6487,1819,12116,1957,0479,8825,3773,8671,7405,383
       Other Current Liabilities 
14,442
328
309
514
191,454
102,304
122,758
212,160
262,644
265,677
298,067
426,981
286,714
282,244
514,650
278,098
517
431,887
970,311
3,104
3,104970,311431,887517278,098514,650282,244286,714426,981298,067265,677262,644212,160122,758102,304191,45451430932814,442
   > Long-term Liabilities 
0
187,757
157,326
153,367
160,201
121,121
170,592
159,261
180,756
169,173
138,535
132,860
126,491
142,694
124,357
136,070
119,022
102,896
203,745
229,377
229,377203,745102,896119,022136,070124,357142,694126,491132,860138,535169,173180,756159,261170,592121,121160,201153,367157,326187,7570
       Capital Lease Obligations 
0
155,068
123,302
119,418
116,977
78,048
137,392
137,822
129,957
121,938
116,550
110,390
99,175
88,317
79,612
71,406
54,064
54,946
172,377
163,586
163,586172,37754,94654,06471,40679,61288,31799,175110,390116,550121,938129,957137,822137,39278,048116,977119,418123,302155,0680
       Long-term Liabilities Other 
0
22,057
21,337
21,299
21,302
23,180
23,607
23,996
22,427
23,125
22,509
23,562
23,775
24,207
27,385
24,363
100
22,355
12,232
12,173
12,17312,23222,35510024,36327,38524,20723,77523,56222,50923,12522,42723,99623,60723,18021,30221,29921,33722,0570
> Total Stockholder Equity
648,010
676,174
637,652
692,482
676,828
727,638
706,228
728,361
888,838
950,168
993,326
925,497
1,023,577
1,167,371
1,059,457
1,200,371
1,325,277
1,453,079
1,073,157
1,264,698
1,264,6981,073,1571,453,0791,325,2771,200,3711,059,4571,167,3711,023,577925,497993,326950,168888,838728,361706,228727,638676,828692,482637,652676,174648,010
   Common Stock
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
544,630
0
544,630
544,630
0
0544,630544,6300544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630544,630
   Retained Earnings 
77,110
100,049
60,408
119,209
115,135
171,437
151,497
171,167
323,741
386,676
431,198
363,889
460,457
593,414
514,570
651,450
698,464
912,664
539,783
595,799
595,799539,783912,664698,464651,450514,570593,414460,457363,889431,198386,676323,741171,167151,497171,437115,135119,20960,408100,04977,110
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
833
3,396
-2,951
-6,922
-8,374
-13,866
-15,336
-12,873
-4,970
-6,575
-7,939
-8,459
-6,947
3,890
-3,394
640
0
-7,866
-14,907
0
0-14,907-7,8660640-3,3943,890-6,947-8,459-7,939-6,575-4,970-12,873-15,336-13,866-8,374-6,922-2,9513,396833



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue882,537
Cost of Revenue-177,177
Gross Profit705,360705,360
 
Operating Income (+$)
Gross Profit705,360
Operating Expense-422,181
Operating Income460,356283,179
 
Operating Expense (+$)
Research Development28,018
Selling General Administrative216,986
Selling And Marketing Expenses-
Operating Expense422,181245,004
 
Net Interest Income (+$)
Interest Income2,092
Interest Expense-451
Other Finance Cost-0
Net Interest Income1,641
 
Pretax Income (+$)
Operating Income460,356
Net Interest Income1,641
Other Non-Operating Income Expenses-
Income Before Tax (EBT)780,277460,356
EBIT - interestExpense = -451
581,674
582,125
Interest Expense451
Earnings Before Interest and Taxes (EBIT)-780,728
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax780,277
Tax Provision-198,603
Net Income From Continuing Ops581,674581,674
Net Income581,674
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--1,641
 

Technical Analysis of Sunmax Biotechnology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sunmax Biotechnology Co Ltd. The general trend of Sunmax Biotechnology Co Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sunmax Biotechnology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sunmax Biotechnology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 252.00 < 287.97.

The bearish price targets are: 200.00 > 197.00 > 195.00.

Tweet this
Sunmax Biotechnology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sunmax Biotechnology Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sunmax Biotechnology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sunmax Biotechnology Co Ltd. The current macd is 6.26208412.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sunmax Biotechnology Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sunmax Biotechnology Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sunmax Biotechnology Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sunmax Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSunmax Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sunmax Biotechnology Co Ltd. The current adx is 51.78.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sunmax Biotechnology Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Sunmax Biotechnology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sunmax Biotechnology Co Ltd. The current sar is 248.70.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sunmax Biotechnology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sunmax Biotechnology Co Ltd. The current rsi is 75.69. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Sunmax Biotechnology Co Ltd Daily Relative Strength Index (RSI) ChartSunmax Biotechnology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sunmax Biotechnology Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sunmax Biotechnology Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sunmax Biotechnology Co Ltd Daily Stochastic Oscillator ChartSunmax Biotechnology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sunmax Biotechnology Co Ltd. The current cci is 230.78.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sunmax Biotechnology Co Ltd Daily Commodity Channel Index (CCI) ChartSunmax Biotechnology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sunmax Biotechnology Co Ltd. The current cmo is 62.02.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sunmax Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartSunmax Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sunmax Biotechnology Co Ltd. The current willr is -21.15384615.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sunmax Biotechnology Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Sunmax Biotechnology Co Ltd Daily Williams %R ChartSunmax Biotechnology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sunmax Biotechnology Co Ltd.

Sunmax Biotechnology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sunmax Biotechnology Co Ltd. The current atr is 8.8243981.

Sunmax Biotechnology Co Ltd Daily Average True Range (ATR) ChartSunmax Biotechnology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sunmax Biotechnology Co Ltd. The current obv is 10,530,942.

Sunmax Biotechnology Co Ltd Daily On-Balance Volume (OBV) ChartSunmax Biotechnology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sunmax Biotechnology Co Ltd. The current mfi is 86.70.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Sunmax Biotechnology Co Ltd Daily Money Flow Index (MFI) ChartSunmax Biotechnology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sunmax Biotechnology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Sunmax Biotechnology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sunmax Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5075.689
Ma 20Greater thanMa 50212.850
Ma 50Greater thanMa 100206.060
Ma 100Greater thanMa 200203.480
OpenGreater thanClose231.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sunmax Biotechnology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sunmax Biotechnology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sunmax Biotechnology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sunmax Biotechnology Co Ltd

I send you an email if I find something interesting about Sunmax Biotechnology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sunmax Biotechnology Co Ltd.

Receive notifications about Sunmax Biotechnology Co Ltd in your mailbox!